Catalyst Pharmaceuticals, Inc.(CPRX)
Pharmaceuticals
Specialty Pharma
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-12-16 | Harper Molly Director | Sale | -26,746 | -91.89%2,360 | $23.25 | $621,920 | View SEC filing | |
| 2025-11-28 | Del Carmen Jeffrey Chief Commercial Officer | Sale | -10,983 | -73.49%3,962 | $23.33 | $256,244 | View SEC filing | |
| 2025-11-14 | Elsbernd Brian Chief Compliance/Legal Officer | Sale | +40,000 | +20.94%231,039 | $22.70 | $908,000 | View SEC filing | |
| 2025-09-10 | Elsbernd Brian Chief Compliance/Legal Officer | Sale | -30,000 | -9.97%271,039 | $20.30 | $609,000 | View SEC filing | |
| 2025-09-05 | Elsbernd Brian Chief Compliance/Legal Officer | Sale | -50,000 | -9.59%188,564 | $19.74 | $987,200 | View SEC filing | |
| 2025-08-28 | Tierney David S Director | Sale | -26,000 | -6.41%379,620 | $20.20 | $525,200 | View SEC filing | |
| 2025-08-28 | Miller Steve Chief Op. & Scientific Officer | Sale | -115,000 | -10.80%949,663 | $20.28 | $2,332,200 | View SEC filing | |
| 2025-08-28 | Daly Richard J President and CEO | Sale | -22,970 | -9.20%226,794 | $20.62 | $473,641 | View SEC filing | |
| 2025-06-12 | Sundaram Preethi Chief Strategy Officer | Sale | -3,924 | -8.72%41,081 | $26.41 | $103,649 | View SEC filing | |
| 2025-06-10 | MCENANY PATRICK J Director, Other | Sale | -200,000 | -4.46%4,281,702 | $26.09 | $5,217,338 | View SEC filing | |
| 2025-06-03 | Daly Richard J President and CEO | Sale | +70,000 | +53.94%199,764 | $24.86 | $1,740,200 | View SEC filing | |
| 2025-05-15 | INGENITO GARY Chief Med. & Reg. Officer | Sale | -244,000 | -74.38%68,873 | $23.67 | $5,775,720 | View SEC filing | |
| 2025-03-07 | INGENITO GARY Chief Med. & Reg. Officer | Sale | -225,000 | -39.47%68,873 | $21.75 | $4,894,610 | View SEC filing | |
| 2025-03-05 | Elsbernd Brian Chief Compliance/Legal Officer | Sale | -62,975 | -4.90%188,564 | $22.98 | $1,446,933 | View SEC filing | |
| 2025-03-05 | Del Carmen Jeffrey Chief Commercial Officer | Sale | -30,423 | -100.00%0 | $22.89 | $696,382 | View SEC filing | |
| 2024-12-11 | Miller Steve Chief Op. & Scientific Officer | Sale | -50,000 | -6.78%686,996 | $21.93 | $1,096,350 | View SEC filing | |
| 2024-11-29 | INGENITO GARY Chief Med. & Reg. Officer | Sale | -12,000 | -18.93%51,391 | $22.72 | $272,654 | View SEC filing | |
| 2024-11-29 | Harper Molly Director | Sale | -17,500 | -100.00%0 | $22.00 | $385,000 | View SEC filing | |
| 2024-11-29 | Elsbernd Brian Chief Compliance/Legal Officer | Sale | -13,256 | -2.00%171,177 | $21.63 | $286,704 | View SEC filing | |
| 2024-11-22 | INGENITO GARY Chief Med. & Reg. Officer | Sale | -38,000 | -42.51%51,391 | $21.20 | $805,562 | View SEC filing | |
| 2024-11-21 | MCENANY PATRICK J Director, Other | Sale | -170,845 | -2.15%4,478,169 | $21.23 | $3,627,259 | View SEC filing | |
| 2024-11-15 | MCENANY PATRICK J Director, Other | Sale | -137,155 | -2.02%4,478,169 | $22.58 | $3,096,801 | View SEC filing | |
| 2024-11-13 | MCENANY PATRICK J Director, Other | Sale | -492,000 | -4.89%4,478,169 | $23.39 | $11,510,102 | View SEC filing | |
| 2024-08-23 | Tierney David S Director | Sale | -15,000 | -4.12%348,874 | $20.10 | $301,455 | View SEC filing | |
| 2024-08-22 | Miller Steve Chief Op. & Scientific Officer | Sale | -150,000 | -18.18%675,124 | $20.35 | $3,052,900 | View SEC filing |
1-25 of 223
Page 1 of 9